An open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA [rheumatoid arthritis]

Trial Profile

An open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA [rheumatoid arthritis]

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Dec 2008

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 14 Dec 2008 Actual end date (August 2005) added as reported by CT.gov
    • 13 Aug 2007 Status changed from in progress to completed.
    • 04 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top